Piperacillin/tazobactam continuous infusion at 12G/1.5G per day in CF patients results in target plasma-concentrations

Kristina Öbrink-Hansen; Søren Jensen-Fangel; Birgitte Brock; Tore Forsingdal Hardlei; Anna Adelfred; Yousef Nejatbakhsh; Marianne Kragh Thomsen; Eskild Petersen

doi:10.1016/j.jcf.2015.10.005

Piperacillin/tazobactam continuous infusion at 12G/1.5G per day in CF patients results in target plasma-concentrations

Kristina Öbrink-Hansen, Søren Jensen-Fangel, Birgitte Brock, Tore Forsingdal Hardlei, Anna Adelfred, Yousef Nejatbakhsh, Marianne Kragh Thomsen, Eskild Petersen

4 Citationer (Scopus)

Originalsprog	Engelsk
Tidsskrift	Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society
Vol/bind	15
Udgave nummer	2
Sider (fra-til)	e13-4
ISSN	1569-1993
DOI	https://doi.org/10.1016/j.jcf.2015.10.005
Status	Udgivet - mar. 2016
Udgivet eksternt	Ja

Adgang til dokumentet

10.1016/j.jcf.2015.10.005

Citationsformater

Öbrink-Hansen, K., Jensen-Fangel, S., Brock, B., Hardlei, T. F., Adelfred, A., Nejatbakhsh, Y., Kragh Thomsen, M., & Petersen, E. (2016). Piperacillin/tazobactam continuous infusion at 12G/1.5G per day in CF patients results in target plasma-concentrations. Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society, 15(2), e13-4. https://doi.org/10.1016/j.jcf.2015.10.005

Piperacillin/tazobactam continuous infusion at 12G/1.5G per day in CF patients results in target plasma-concentrations. / Öbrink-Hansen, Kristina; Jensen-Fangel, Søren; Brock, Birgitte et al.
I: Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society, Bind 15, Nr. 2, 03.2016, s. e13-4.

Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning

Öbrink-Hansen, K, Jensen-Fangel, S, Brock, B, Hardlei, TF, Adelfred, A, Nejatbakhsh, Y, Kragh Thomsen, M & Petersen, E 2016, 'Piperacillin/tazobactam continuous infusion at 12G/1.5G per day in CF patients results in target plasma-concentrations', Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society, bind 15, nr. 2, s. e13-4. https://doi.org/10.1016/j.jcf.2015.10.005

@article{c52adc8da2ff4b879c2b4cadd8300349,

title = "Piperacillin/tazobactam continuous infusion at 12G/1.5G per day in CF patients results in target plasma-concentrations",

keywords = "Anti-Bacterial Agents, Cystic Fibrosis, Dose-Response Relationship, Drug, Humans, Infusions, Intravenous, Penicillanic Acid, Piperacillin, Letter",

author = "Kristina {\"O}brink-Hansen and S{\o}ren Jensen-Fangel and Birgitte Brock and Hardlei, {Tore Forsingdal} and Anna Adelfred and Yousef Nejatbakhsh and {Kragh Thomsen}, Marianne and Eskild Petersen",

year = "2016",

month = mar,

doi = "10.1016/j.jcf.2015.10.005",

language = "English",

volume = "15",

pages = "e13--4",

journal = "Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society",

issn = "1569-1993",

publisher = "Elsevier BV",

number = "2",

}

TY - JOUR

T1 - Piperacillin/tazobactam continuous infusion at 12G/1.5G per day in CF patients results in target plasma-concentrations

AU - Öbrink-Hansen, Kristina

AU - Jensen-Fangel, Søren

AU - Brock, Birgitte

AU - Hardlei, Tore Forsingdal

AU - Adelfred, Anna

AU - Nejatbakhsh, Yousef

AU - Kragh Thomsen, Marianne

AU - Petersen, Eskild

PY - 2016/3

Y1 - 2016/3

KW - Anti-Bacterial Agents

KW - Cystic Fibrosis

KW - Dose-Response Relationship, Drug

KW - Humans

KW - Infusions, Intravenous

KW - Penicillanic Acid

KW - Piperacillin

KW - Letter

U2 - 10.1016/j.jcf.2015.10.005

DO - 10.1016/j.jcf.2015.10.005

M3 - Journal article

C2 - 26490337

SN - 1569-1993

VL - 15

SP - e13-4

JO - Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society

JF - Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society

IS - 2

ER -